$38.07B
Revenue
$4.88B
Net Income
19.79%
Gross Margin
3.65%
Op. Margin
$5.85B
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $10.96B | $9.97B | $9.11B | $8.03B | $10.56B | $8.91B | $8.20B | $7.26B |
| Revenue Growth % (YoY) | 3.8% | 11.8% | 11.1% | 10.6% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $8.63B | $8.07B | $7.27B | $6.56B | $8.44B | $7.80B | $6.50B | $6.11B |
| Gross Profit | $2.32B | $1.90B | $1.85B | $1.47B | $2.12B | $1.11B | $1.70B | $1.15B |
| Gross Margin % | 21.2% | 19.0% | 20.3% | 18.3% | 20.1% | 12.4% | 20.7% | 15.8% |
| Research & Development | $365.00M | $310.00M | $282.00M | $239.00M | $265.00M | $243.00M | $237.00M | $237.00M |
| Selling General & Admin | $1.35B | $1.22B | $1.19B | $1.19B | $1.27B | $1.23B | $938.00M | $1.20B |
| Operating Income | $601.00M | $366.00M | $378.00M | $43.00M | $593.00M | $-359.00M | $527.00M | $-289.00M |
| Operating Margin % | 5.5% | 3.7% | 4.1% | 0.5% | 5.6% | -4.0% | 6.4% | -4.0% |
| Other Income/Expense | $340.00M | $221.00M | $115.00M | $119.00M | $347.00M | $71.00M | $881.00M | $73.00M |
| Income Before Tax | $1.10B | $746.00M | $645.00M | $332.00M | $1.11B | $-122.00M | $1.60B | $-96.00M |
| Income Tax Expense | $-2.56B | $293.00M | $153.00M | $68.00M | $629.00M | $-23.00M | $322.00M | $10.00M |
| Net Income | $3.66B | $452.00M | $514.00M | $254.00M | $484.00M | $-96.00M | $1.29B | $-130.00M |
| Net Margin % | 33.4% | 4.5% | 5.6% | 3.2% | 4.6% | -1.1% | 15.8% | -1.8% |
| Basic EPS | nan | 1.66 | 1.89 | 0.92 | 1.75 | -0.35 | 4.72 | nan |
| Diluted EPS | nan | 1.64 | 1.86 | 0.91 | 1.73 | -0.35 | 4.65 | nan |
| Basic Shares Outstanding | -1.0M | 272.0M | 272.0M | 275.0M | 1.0M | 275.0M | 274.0M | - |
| Diluted Shares Outstanding | -1.0M | 275.0M | 276.0M | 279.0M | 1.0M | 275.0M | 278.0M | - |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|---|
| Accounts Receivable | $9.80B | $7.37B | $6.95B | $7.14B | $8.18B | - | - | - |
| Inventory | $10.43B | $10.03B | $9.82B | $9.16B | $8.59B | $9.38B | $9.35B | $8.86B |
| Other Current Assets | $1.45B | $934.00M | $555.00M | $497.00M | $562.00M | $550.00M | $463.00M | $462.00M |
| Total Current Assets | $40.22B | $36.28B | $34.71B | $33.94B | $34.15B | $33.14B | $30.72B | $29.24B |
| Goodwill | $4.44B | $4.33B | $4.53B | $4.37B | $4.26B | $4.44B | $4.35B | $4.40B |
| Intangible Assets | $727.00M | $747.00M | $739.00M | $773.00M | $813.00M | $869.00M | $925.00M | $991.00M |
| Other Non-current Assets | $4.09B | $3.41B | $3.28B | $2.98B | $2.76B | $2.76B | $2.48B | $2.30B |
| Total Assets | $63.02B | $54.40B | $53.08B | $51.56B | $51.48B | $50.85B | $48.05B | $47.87B |
| Short-term Debt | $63.00M | - | - | - | $60.00M | - | - | - |
| Deferred Revenue | $25.77B | $20.15B | $19.60B | $18.71B | $17.59B | $16.91B | $16.54B | $15.92B |
| Other Current Liabilities | $6.31B | $5.50B | $5.12B | $5.55B | $5.50B | $5.32B | $4.64B | $4.40B |
| Total Current Liabilities | $40.97B | $35.27B | $33.76B | $32.68B | $31.68B | $31.23B | $29.07B | $29.52B |
| Deferred Tax Liabilities | $1.16B | $820.00M | $818.00M | $782.00M | $827.00M | $823.00M | $674.00M | $423.00M |
| Other Non-current Liabilities | $5.42B | $5.38B | $5.31B | $5.18B | $5.12B | $5.05B | $5.04B | $4.69B |
| Total Liabilities | $50.72B | $44.67B | $43.13B | $41.89B | $40.89B | $40.34B | $38.00B | $37.89B |
| Common Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | - |
| Retained Earnings | $6.15B | $2.63B | $2.24B | $1.86B | $1.61B | $1.20B | $1.29B | - |
| Total Stockholders Equity | $11.18B | $8.65B | $8.88B | $8.61B | $9.55B | $9.50B | $9.07B | $8.97B |
| Total Liabilities & Equity | $63.02B | $54.40B | $53.08B | $51.56B | $51.48B | $50.85B | $48.05B | $47.87B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
Q1 2024 (Mar 31, 2024) |
|---|---|---|---|---|---|---|---|---|
| Net Income | $3.66B | $452.00M | $514.00M | $254.00M | $484.00M | $1.07B | $1.16B | $-130.00M |
| Change in Inventory | $386.00M | $1.05B | $883.00M | $432.00M | $-510.00M | $1.15B | $1.29B | $717.00M |
| Operating Cash Flow | $2.48B | $2.51B | $1.53B | $1.16B | $921.00M | $1.66B | $535.00M | $-444.00M |
| Capital Expenditure | $671.00M | $606.00M | $359.00M | $186.00M | $350.00M | $533.00M | $374.00M | $217.00M |
| Investing Cash Flow | $-374.00M | $-381.00M | $-214.00M | $-93.00M | $-175.00M | $138.00M | $252.00M | $-285.00M |
| Stock Repurchased | $1.07B | $2.24B | $1.58B | $1.10B | $3.00M | - | - | - |
| Dividends Paid | $68.00M | $207.00M | $139.00M | $69.00M | - | - | - | - |
| Financing Cash Flow | $-1.18B | $-2.63B | $-1.86B | $-1.26B | $163.00M | $3.49B | $2.90B | $1.93B |
| Net Change in Cash | $902.00M | $-258.00M | $-312.00M | $-98.00M | $810.00M | $5.24B | $3.62B | $1.17B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $9.97B | $8.91B | $27.11B | $24.38B |
| Cost of Revenue | $8.07B | $7.80B | $21.90B | $20.41B |
| Gross Profit | $1.90B | $1.11B | $5.21B | $3.96B |
| Research & Development | $310.00M | $243.00M | $832.00M | $717.00M |
| Selling General & Admin | $1.22B | $1.23B | $3.59B | $3.37B |
| Operating Income | $366.00M | $-359.00M | $787.00M | $-122.00M |
| Other Income/Expense | $221.00M | $71.00M | $455.00M | $1.02B |
| Income Before Tax | $746.00M | $-122.00M | $1.72B | $1.39B |
| Income Tax Expense | $293.00M | $-23.00M | $514.00M | $310.00M |
| Net Income | $452.00M | $-96.00M | $1.22B | $1.07B |
| Basic EPS | 1.66 | -0.35 | 4.47 | 3.90 |
| Diluted EPS | 1.64 | -0.35 | 4.41 | 3.85 |
| Basic Shares Outstanding | $272.00M | $275.00M | $273.00M | $274.00M |
| Diluted Shares Outstanding | $275.00M | $275.00M | $277.00M | $277.00M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Accounts Receivable | $7.37B | $8.18B |
| Inventory | $10.03B | $8.59B |
| Other Current Assets | $934.00M | $564.00M |
| Total Current Assets | $36.28B | $34.15B |
| Goodwill | $4.33B | $4.26B |
| Intangible Assets | $747.00M | $813.00M |
| Other Non-current Assets | $3.41B | $2.76B |
| Total Assets | $54.40B | $51.48B |
| Deferred Revenue | $20.15B | $17.59B |
| Other Current Liabilities | $5.50B | $5.50B |
| Total Current Liabilities | $35.27B | $31.68B |
| Deferred Tax Liabilities | $820.00M | $827.00M |
| Other Non-current Liabilities | $5.38B | $5.12B |
| Total Liabilities | $44.67B | $40.89B |
| Common Stock | $3.00M | $3.00M |
| Retained Earnings | $2.63B | $1.61B |
| Total Stockholders Equity | $8.65B | $9.55B |
| Total Liabilities & Equity | $54.40B | $51.48B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $452.00M | $-96.00M | $1.22B | $1.07B |
| Change in Inventory | - | - | $1.05B | $1.15B |
| Operating Cash Flow | - | - | $2.51B | $1.66B |
| Capital Expenditure | - | - | $606.00M | $533.00M |
| Investing Cash Flow | - | - | $-381.00M | $138.00M |
| Stock Repurchased | - | - | $2.24B | $40.00M |
| Dividends Paid | - | - | $207.00M | - |
| Financing Cash Flow | - | - | $-2.63B | $3.49B |
| Net Change in Cash | - | - | $-258.00M | $5.24B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.